COMPANY PROFILE · UPDATED 18 NOV 2025

ESCAPE Bio

Escape Bio, Inc. operates as a preclinical stage biopharmaceutical company. The Company discovers and develops small molecule drugs and medicines to treat genetically-defined subpopulations in neurodegenerative diseases. Escape Bio serves…

escapebio.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2015
Headcount: 24
Open roles: 0
Last raised: Series B · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Roles at ESCAPE Bio

Employbl doesn’t track ESCAPE Bio’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$187,076,080

Investors

Avidity PartnersCAM CapitalJohnson & Johnson InnovationJohnson & Johnson Robotics and Digital SolutionsNew Leaf VenturesNovartis Venture FundNovo HoldingsOrbiMed AdvisorsOsage University Partners IIRock Springs CapitalSphera Funds ManagementSurveyor CapitalSutter Hill VenturesWellington Management

Funding rounds

Series B
Wellington Management, Surveyor Capital, Avidity Partners, CAM Capital, New Leaf Ventures, Johnson & Johnson Innovation, Osage University Partners II, OrbiMed Advisors, Novartis Venture Fund, Novo Holdings, Sphera Funds Management, Sutter Hill Ventures, Rock Springs Capital
$73MSep 13, 2020
Series Unknown
$31.1MJul 15, 2019
Series A
OrbiMed Advisors, Novo Holdings, Johnson & Johnson Robotics and Digital Solutions, Novartis Venture Fund, Osage University Partners II, Sutter Hill Ventures
$63MJul 11, 2017
Series Unknown
$20MAug 18, 2015

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

ESCAPE Bio offices

Loading map…

South San Francisco, CA4000 Shoreline Ct suite 400